This week, it was announced that Usana Health Sciences (NASDAQ:USNA) and Fraud Discovery Institute had reached a settlement in their legal battle. Usana basically had most of its case thrown out by a federal judge, but still could have pursued allegations of illegal manipulation of the stock.

The most interesting thing about the whole case against Barry Minkow and FDI is that Usana repeatedly called the report issued by Barry “false and misleading.” Yet the company never addressed any of the substantive allegations in the report or proved that they were incorrect. And no one held their feet to the fire and demanded that they prove that what he said was false. Continue reading